The healthcare industry is undergoing significant transformation with rapid advancements in the diagnostic testing market, clinical laboratory testing, and infectious disease diagnostics. Accurate and timely diagnosis has become a critical component of modern healthcare, enabling early disease detection, effective treatment planning, and improved patient outcomes. Growing disease...

Market Overview The Global Anatomic Pathology Market was valued at USD 22 Billion in 2022 and is forecast to reach USD 89.59 Billion by 2029, expanding at a CAGR of 22.2% during 2023–2029. Increasing demand for accurate tissue-based diagnosis, the growing burden of cancer and chronic diseases, rising use of biomarkers, and adoption of advanced pathology equipment...

The cancer biomarkers market is entering a period of strong expansion as rising cancer cases, increasing emphasis on early diagnosis, and growing adoption of personalized treatment continue to reshape oncology care. According to Grand View Research, the market size was valued at USD 26.9 billion in 2025 and is projected to increase from USD 29.9 billion in 2026 to USD 65.3 billion by 2033,...

The companion diagnostics market is becoming increasingly important as healthcare moves from broad treatment approaches toward precision medicine and biomarker-guided therapies. The market was valued at USD 9.6 billion in 2025 and is projected to grow from USD 10.3 billion in 2026 to USD 20.1 billion by 2033, registering a CAGR of 10.1% from 2026 to 2033. Increasing demand for precision...